Jacoprazole

Lansoprazole, the active ingredient in Jacoprazole, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is used to treat gastro‑oesophageal reflux disease, erosive oesophagitis, peptic ulcer disease and Helicobacter pylori infection in adult patients.

GNH USA supplies Jacoprazole as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Jacoprazole (lansoprazole) is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders.

- Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief by reducing gastric acid exposure to the esophagus. - Erosive oesophagitis: promotes healing of damaged esophageal mucosa through acid suppression. - Peptic ulcer disease: facilitates ulcer healing and prevents recurrence by maintaining a low‑acid environment. - Helicobacter pylori eradication regimen: acts as a component of combination therapy to increase eradication rates by decreasing gastric acidity.

Adverse reactions may occur with any dosage form of lansoprazole.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: watery stools, usually transient. - Abdominal pain: discomfort or cramping in the stomach area. - Nausea: feeling of queasiness, sometimes with vomiting.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent diarrhea, abdominal pain. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Liver enzyme elevation: signs of hepatitis, jaundice. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement. - Interstitial nephritis: kidney inflammation, reduced urine output.

Before initiating therapy, consider the following safety measures.

- Renal function assessment: adjust use in patients with severe renal impairment. - Magnesium monitoring: check serum magnesium during prolonged treatment. - Elderly patients: use caution due to higher risk of fractures. - Rebound acid hypersecretion: avoid abrupt discontinuation after long‑term use. - Concomitant medication review: assess for potential drug interactions. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lansoprazole may affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Clarithromycin: increased risk of cardiac arrhythmias. - Ketoconazole: markedly reduced antifungal absorption. - Atazanavir: decreased antiviral efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of anticoagulant effect. - Digoxin: potential increase in serum levels. - Methotrexate: reduced clearance leading to toxicity.